Table 1 Baseline characteristics
From: Tricuspid valve repair in isolated tricuspid pathology: a 12-year single center experience
| Characteristics | Value |
|---|---|
| Demographic data | |
| Age (years) | 58.1 ± 21.6 |
| Female | 16 (61.5%) |
| BMI | 24.7 ± 4.7 |
| Angina pectoris | |
| CCS III | 3 (11,5%) |
| Dyspnea | |
| NYHA I-II | 6 (23%) |
| NYHA III-IV | 20 (76.9%) |
| Pulmonary edema | 3 (11.5%) |
| Peripheral edema | 16 (61.5%) |
| Chronic kidney injury (GFR 30–60) | 19 (73.1%) |
| Coronary artery disease | 10 (38.5%) |
| Previous PCI | 5 (19.2%) |
| Mitral regurgitation ≥II | 5 (19.2%) |
| Septic embolization | 3 (11.5%) |
| Previous decompensation | 7 (26.9%) |
| Previous cardiopulmonary resuscitation | 1 (3.8%) |
| Mechanical ventilation | 2 (7.7%) |
| Mechanical circulatory support | |
| ECLS | 1 (3.8%) |
| Cardiovascular risk factors | |
| Hyperlipidemia | 12 (46.2%) |
| Hypertension | 18 (69.1%) |
| Smoking history | 13 (50%) |
| Diabetes mellitus | |
| NIDDM | 3 (11.5%) |
| Pulmonary hypertension | 11 (42.3%) |
| Atrial fibrillation | 15 (57.7%) |
| Paroxysmal | 6 (23.1%) |
| Permanent | 9 (34.6%) |
| Previous stroke | 4 (15.4%) |
| History of sternotomy | 7 (26.9%) |
| Prior cardiac surgery | |
| Coronary surgery | 2 (7.7%) |
| Aortic valve surgery | 2 (7.7%) |
| Mitral valve surgery | 4 (15.4%) |
| Tricuspid valve surgery | 3 (11.5%) |
| Pacemaker implantation | 6 (23.1%) |
| Infection | 12 (46.2%) |
| Antibiotics | 12 (46.2%) |
| Intravenous drugs abuse | 7 (26.9%) |
| Left ventricular ejection fraction | median 60 (54,5–60) |
| EuroSCORE II | median 4.9 (3.4–12.0) |
| Right ventricular function imparement | |
| Mild (TAPSE< 15) | 5 (19.2%) |
| Moderate (TAPSE < 10) | 2 (7.7%) |
| Right ventricular-dilatation (mid-cavity-diameter > 4 cm) | 11 (42.3%) |
| Pulmonary hypertension (mean > 40 mmHg) | 11 (42.3%) |
| Severe tricuspid regurgitation (≥III°) | 21 (80.8%) |